Exact Mass: 314.1682

Exact Mass Matches: 314.1682

Found 152 metabolites which its exact mass value is equals to given mass value 314.1682, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Magnocurarine

Isoquinolinium, 1,2,3,4-tetrahydro-7-hydroxy-1-((4-hydroxyphenyl)methyl)-6-methoxy-2,2-dimethyl-, (R)-

C19H24NO3+ (314.1756)


Magnocurarine is a member of isoquinolines. Magnocurarine is a natural product found in Lindera megaphylla, Litsea cubeba, and other organisms with data available.

   

Lotusine

Isoquinolinium, 1,2,3,4-tetrahydro-6-hydroxy-1-[(4-hydroxyphenyl)methyl]-7-methoxy-2,2-dimethyl-, (1R)-

C19H24NO3+ (314.1756)


Lotusine is a member of isoquinolines. Lotusine is a natural product found in Nelumbo nucifera, Magnolia officinalis, and Xylopia parviflora with data available. Quaternary alkaloid from the embryo of Nelumbo nucifera (East India lotus). Lotusine is found in coffee and coffee products. Lotusine is found in coffee and coffee products. Quaternary alkaloid from the embryo of Nelumbo nucifera (East India lotus).

   

WIN VI

5-(5-(4-(4,5-Dihydro-2-oxazoly)phenoxy)pentyl)-3-methylisoxazole

C18H22N2O3 (314.163)


   

dapdiamide B

Dapdiamide B; 3-{[(2E)-4-Amino-4-oxobut-2-enoyl]amino}-L-alanyl-L-isoleucine

C13H22N4O5 (314.159)


A member of the family of dapdiamides consisting of alanylisoleucine, in which one of the methyl hydrogens of alanine is replaced by a fumaramoyl group.

   

dapdiamide C

Dapdiamide C; 3-{[(2E)-4-Amino-4-oxobut-2-enoyl]amino}-L-alanyl-L-leucine

C13H22N4O5 (314.159)


A member of the family of dapdiamides consisting of alanylleucine, in which one of the methyl hydrogens of alanine is replaced by a fumaramoyl group.

   

Oblongine

8-hydroxy-1-[(4-hydroxyphenyl)methyl]-7-methoxy-2,2-dimethyl-1,2,3,4-tetrahydroisoquinolin-2-ium

C19H24NO3+ (314.1756)


Oblongine is a member of isoquinolines. Oblongine is a natural product found in Stephania cephalantha, Stephania tetrandra, and other organisms with data available. Oblongine is found in fruits. Quaternary alkaloid from stems of Litsea cubeba (mountain pepper). Quaternary alkaloid from stems of Litsea cubeba (mountain pepper). Oblongine is found in fruits.

   

Perilloside A

2-(hydroxymethyl)-6-{[4-(prop-1-en-2-yl)cyclohex-1-en-1-yl]methoxy}oxane-3,4,5-triol

C16H26O6 (314.1729)


Constituent of Perilla frutescens (perilla). Perilloside A is found in fats and oils and herbs and spices. Perilloside A is found in fats and oils. Perilloside A is a constituent of Perilla frutescens (perilla).

   

(-)-trans-Carveol glucoside

(2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-{[(1S,5R)-2-methyl-5-(prop-1-en-2-yl)cyclohex-2-en-1-yl]oxy}oxane-3,4,5-triol

C16H26O6 (314.1729)


(-)-trans-Carveol glucoside is found in citrus. (-)-trans-Carveol glucoside is a constituent of Citrus species and ginger mint Mentha gentilis cardiaca Constituent of Citrus subspecies and ginger mint Mentha gentilis cardiaca. (-)-trans-Carveol glucoside is found in citrus.

   

(+)-trans-Carveol glucoside

(2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-{[(1R,5S)-2-methyl-5-(prop-1-en-2-yl)cyclohex-2-en-1-yl]oxy}oxane-3,4,5-triol

C16H26O6 (314.1729)


(+)-trans-Carveol glucoside is found in citrus. (+)-trans-Carveol glucoside is a constituent of Citrus species Constituent of Citrus subspecies (+)-trans-Carveol glucoside is found in citrus.

   

17-Ethynyl-16-fluoroestradiol

17-ethynyl-16-fluoro-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol

C20H23FO2 (314.1682)


   

Resiquimod

1-[2-(ethoxymethyl)-4-imino-1H,4H,5H-imidazo[4,5-c]quinolin-1-yl]-2-methylpropan-2-ol

C17H22N4O2 (314.1743)


C308 - Immunotherapeutic Agent > C129820 - Antineoplastic Immunomodulating Agent C274 - Antineoplastic Agent

   

7-Methoxy tropisetron

8-Methyl-8-azabicyclo[3.2.1]octan-3-yl 7-methoxy-1H-indole-3-carboxylic acid

C18H22N2O3 (314.163)


   

Gigantamide A

Gigantamide A

C18H22N2O3 (314.163)


   

3,3,6-Trimethyl-5-heptene-1,2,4-triol

3,3,6-Trimethyl-5-heptene-1,2,4-triol

C16H26O6 (314.1729)


   
   

(2R,3R,4S,5S,6R)-2-[(2E)-4-ethenyl-2,5-dimethylhexa-2,5-dienoxy]-6-(hydroxymethyl)oxane-3,4,5-triol

(2R,3R,4S,5S,6R)-2-[(2E)-4-ethenyl-2,5-dimethylhexa-2,5-dienoxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C16H26O6 (314.1729)


   

myrtenol 10-O-beta-D-glucopyranoside|myrtenyl 10-O-beta-D-glucopyranoside|myrtenyl O-beta-D-glucopyranoside

myrtenol 10-O-beta-D-glucopyranoside|myrtenyl 10-O-beta-D-glucopyranoside|myrtenyl O-beta-D-glucopyranoside

C16H26O6 (314.1729)


   

limonen-10-ol 10-O-beta-D-glucopyranoside|Limonene-10-ol 10-O-??-D-glucopyranoside

limonen-10-ol 10-O-beta-D-glucopyranoside|Limonene-10-ol 10-O-??-D-glucopyranoside

C16H26O6 (314.1729)


   

(-)-cis-chrysanthenol-beta-D-galactopyranoside

(-)-cis-chrysanthenol-beta-D-galactopyranoside

C16H26O6 (314.1729)


   

seco-dihydropyrenophorin-1,4-lactone

seco-dihydropyrenophorin-1,4-lactone

C16H26O6 (314.1729)


   

manadoperoxide C

manadoperoxide C

C16H26O6 (314.1729)


   

1,3,5-triphenylpentan-1-one

1,3,5-triphenylpentan-1-one

C23H22O (314.1671)


   

p-menth-1(7),4(8)-diene-3-yl beta-D-glucopyranoside

p-menth-1(7),4(8)-diene-3-yl beta-D-glucopyranoside

C16H26O6 (314.1729)


   

N-[(3E)-4-methylhex-3-enoyl]-L-tryptophan|streptomycindole

N-[(3E)-4-methylhex-3-enoyl]-L-tryptophan|streptomycindole

C18H22N2O3 (314.163)


   

leucomidine C

leucomidine C

C18H22N2O3 (314.163)


   

3alpha,4alpha,8alpha-trihydroxy-10alpha-methoxy-1alpha,5alpha,7alpha,11-betaH-guaia,6,12-olide

3alpha,4alpha,8alpha-trihydroxy-10alpha-methoxy-1alpha,5alpha,7alpha,11-betaH-guaia,6,12-olide

C16H26O6 (314.1729)


   

p-mentha-1(7),8-dien-2-O-beta-D-glucoside

p-mentha-1(7),8-dien-2-O-beta-D-glucoside

C16H26O6 (314.1729)


   

peroxyplakoric ester C

peroxyplakoric ester C

C16H26O6 (314.1729)


   

(-)-trans-verbenol beta-D-glucopyranoside

(-)-trans-verbenol beta-D-glucopyranoside

C16H26O6 (314.1729)


   

O=C(CCCCC(=O)O)CCCCC(CCCCC(=O)O)=O

O=C(CCCCC(=O)O)CCCCC(CCCCC(=O)O)=O

C16H26O6 (314.1729)


   
   
   
   
   

p-Hydroxyminaprine

p-Hydroxyminaprine

C17H22N4O2 (314.1743)


   

7-carboxy-N-geranyl-L-gluatamic acid

7-carboxy-N-geranyl-L-gluatamic acid

[C15H24NO6]+ (314.1604)


   

(2R,3R,4S,5S,6R)-2-[(2E)-4-ethenyl-2,5-dimethylhexa-2,5-dienoxy]-6-(hydroxymethyl)oxane-3,4,5-triol_major

(2R,3R,4S,5S,6R)-2-[(2E)-4-ethenyl-2,5-dimethylhexa-2,5-dienoxy]-6-(hydroxymethyl)oxane-3,4,5-triol_major

C16H26O6 (314.1729)


   

Ala Ala Gly Pro

(2S)-1-{2-[(2S)-2-[(2S)-2-aminopropanamido]propanamido]acetyl}pyrrolidine-2-carboxylic acid

C13H22N4O5 (314.159)


   

Ala Ala Pro Gly

2-{[(2S)-1-[(2S)-2-[(2S)-2-aminopropanamido]propanoyl]pyrrolidin-2-yl]formamido}acetic acid

C13H22N4O5 (314.159)


   

Ala Gly Ala Pro

(2S)-1-[(2S)-2-{2-[(2S)-2-aminopropanamido]acetamido}propanoyl]pyrrolidine-2-carboxylic acid

C13H22N4O5 (314.159)


   

Ala Gly Pro Ala

(2S)-2-{[(2S)-1-{2-[(2S)-2-aminopropanamido]acetyl}pyrrolidin-2-yl]formamido}propanoic acid

C13H22N4O5 (314.159)


   

Ala Pro Ala Gly

2-[(2S)-2-{[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidin-2-yl]formamido}propanamido]acetic acid

C13H22N4O5 (314.159)


   

Ala Pro Gly Ala

(2S)-2-(2-{[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidin-2-yl]formamido}acetamido)propanoic acid

C13H22N4O5 (314.159)


   

Gly Ala Ala Pro

(2S)-1-[(2S)-2-[(2S)-2-(2-aminoacetamido)propanamido]propanoyl]pyrrolidine-2-carboxylic acid

C13H22N4O5 (314.159)


   

Gly Ala Pro Ala

(2S)-2-{[(2S)-1-[(2S)-2-(2-aminoacetamido)propanoyl]pyrrolidin-2-yl]formamido}propanoic acid

C13H22N4O5 (314.159)


   

Gly Pro Ala Ala

(2S)-2-[(2S)-2-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}propanamido]propanoic acid

C13H22N4O5 (314.159)


   

Ergoline-1-carboxaldehyde, 8-(hydroxymethyl)-10-methoxy-6-methyl-, (8b)-

Ergoline-1-carboxaldehyde, 8-(hydroxymethyl)-10-methoxy-6-methyl-, (8b)-

C18H22N2O3 (314.163)


   
   
   

Pro Ala Ala Gly

2-[(2S)-2-[(2S)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]propanamido]acetic acid

C13H22N4O5 (314.159)


   

Pro Ala Gly Ala

(2S)-2-{2-[(2S)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]acetamido}propanoic acid

C13H22N4O5 (314.159)


   

Pro Gly Ala Ala

(2S)-2-[(2S)-2-{2-[(2S)-pyrrolidin-2-ylformamido]acetamido}propanamido]propanoic acid

C13H22N4O5 (314.159)


   
   

Granisetron metabolite 4

Granisetron metabolite 4

C17H22N4O2 (314.1743)


   

(-)-trans-Carveol glucoside

(2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-{[(1S,5R)-2-methyl-5-(prop-1-en-2-yl)cyclohex-2-en-1-yl]oxy}oxane-3,4,5-triol

C16H26O6 (314.1729)


   

(+)-trans-Carveol glucoside

(2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-{[(1R,5S)-2-methyl-5-(prop-1-en-2-yl)cyclohex-2-en-1-yl]oxy}oxane-3,4,5-triol

C16H26O6 (314.1729)


   

Lotusine

6-hydroxy-1-[(4-hydroxyphenyl)methyl]-7-methoxy-2,2-dimethyl-1,2,3,4-tetrahydroisoquinolin-2-ium

C19H24NO3 (314.1756)


   

Perilloside A

(2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-[[(4S)-4-isopropenyl-1-cyclohexenyl]methoxy]tetrahydropyran-3,4,5-triol

C16H26O6 (314.1729)


   

Oblongine

8-hydroxy-1-[(4-hydroxyphenyl)methyl]-7-methoxy-2,2-dimethyl-1,2,3,4-tetrahydroisoquinolin-2-ium

C19H24NO3+ (314.1756)


   

4,4-DI-N-PROPOXYAZOXYBENZENE

4,4-DI-N-PROPOXYAZOXYBENZENE

C18H22N2O3 (314.163)


   

Moxiraprine

Moxiraprine

C17H22N4O2 (314.1743)


C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent

   

4-isopropyl-2,5-dioxoimidazolidine-1,3-di(propionohydrazide)

4-isopropyl-2,5-dioxoimidazolidine-1,3-di(propionohydrazide)

C12H22N6O4 (314.1702)


   

4-Hydroxy-6,7-diisobutoxy-3-quinolinecarbonitrile

4-Hydroxy-6,7-diisobutoxy-3-quinolinecarbonitrile

C18H22N2O3 (314.163)


   

butyl prop-2-enoate,2-methylidenebutanoic acid,2-methylprop-2-enoic acid

butyl prop-2-enoate,2-methylidenebutanoic acid,2-methylprop-2-enoic acid

C16H26O6 (314.1729)


   
   

dibutyl (Z)-but-2-enedioate,ethenyl acetate

dibutyl (Z)-but-2-enedioate,ethenyl acetate

C16H26O6 (314.1729)


   

4-[(2R)-2-(Chloromethyl)-3-methylbutyl]-1-methoxy-2-(3-methoxypropoxy)benzene

4-[(2R)-2-(Chloromethyl)-3-methylbutyl]-1-methoxy-2-(3-methoxypropoxy)benzene

C17H27ClO3 (314.1649)


   

hc yellow no. 7

hc yellow no. 7

C17H22N4O2 (314.1743)


   

butyl prop-2-enoate,ethenyl acetate,methyl 2-methylprop-2-enoate

butyl prop-2-enoate,ethenyl acetate,methyl 2-methylprop-2-enoate

C16H26O6 (314.1729)


   

SODIUM HEXETH-4 CARBOXYLATE

SODIUM HEXETH-4 CARBOXYLATE

C14H27NaO6 (314.1705)


   

TERT-BUTYL 3-(2-CYANOPROPAN-2-YL)-5-METHOXY-1H-INDOLE-1-CARBOXYLATE

TERT-BUTYL 3-(2-CYANOPROPAN-2-YL)-5-METHOXY-1H-INDOLE-1-CARBOXYLATE

C18H22N2O3 (314.163)


   

5-METHYL-2-((4-(2-(PYRROLIDIN-1-YL)ETHOXY)PHENYL)AMINO)PYRIMIDIN-4(3H)-ONE

5-METHYL-2-((4-(2-(PYRROLIDIN-1-YL)ETHOXY)PHENYL)AMINO)PYRIMIDIN-4(3H)-ONE

C17H22N4O2 (314.1743)


   

butyl 2-methylprop-2-enoate,methyl 2-methylprop-2-enoate,prop-2-enoic acid

butyl 2-methylprop-2-enoate,methyl 2-methylprop-2-enoate,prop-2-enoic acid

C16H26O6 (314.1729)


   
   

2-(Aminomethyl)phenol

2-(Aminomethyl)phenol

C17H22N4O2 (314.1743)


   

Cyclobenzaprine-D3 Hydrochloride

Cyclobenzaprine-D3 Hydrochloride

C20H19ClD3N (314.1629)


   

BIS(4-(VINYLOXY)BUTYL) SUCCINATE

BIS(4-(VINYLOXY)BUTYL) SUCCINATE

C16H26O6 (314.1729)


   

Dimethocaine hydrochloride

Dimethocaine hydrochloride

C16H27ClN2O2 (314.1761)


   

Fluoxetine-d5 solution

Fluoxetine-d5 solution

C17H13D5F3NO (314.1654)


   

Sildenafil Impurity

Sildenafil Impurity

C17H22N4O2 (314.1743)


   

Pentaethylene glycol monophenyl ether

Pentaethylene glycol monophenyl ether

C16H26O6 (314.1729)


   

Poly(oxy-1,2-ethanediyl), alpha,alpha-1,6-hexanediylbis(omega-((1-oxo-2-propenyl)oxy)

Poly(oxy-1,2-ethanediyl), alpha,alpha-1,6-hexanediylbis(omega-((1-oxo-2-propenyl)oxy)

C16H26O6 (314.1729)


   

(2,3-dipentylphenyl) dihydrogen phosphate

(2,3-dipentylphenyl) dihydrogen phosphate

C16H27O4P (314.1647)


   

3-HYDROXY-N-[3-(4-MORPHOLINYL)PROPYL]-2-NAPHTHALENECARBOXAMIDE

3-HYDROXY-N-[3-(4-MORPHOLINYL)PROPYL]-2-NAPHTHALENECARBOXAMIDE

C18H22N2O3 (314.163)


   

Ralmitaront

Ralmitaront

C17H22N4O2 (314.1743)


C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent Ralmitaront (RO6889450) is an orally active agonist of trace amine-associated receptor 1 (TAAR1) with a EC50 value of 110.4 nM. Ralmitaront has antipsychotic, cognitively improvement, and antidepressant activity in rodents. Ralmitaront can be used as a neurosuppressant in the study of neuro-related diseases, such as schizophrenia (SCZ), schizoaffective disorder[1][2][3][4].

   

Ethidium

Ethidium

C21H20N3+ (314.1657)


D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D049408 - Luminescent Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent D004396 - Coloring Agents > D005456 - Fluorescent Dyes D004791 - Enzyme Inhibitors

   

Lotusine

Isoquinolinium, 1,2,3,4-tetrahydro-6-hydroxy-1-[(4-hydroxyphenyl)methyl]-7-methoxy-2,2-dimethyl-, (1R)-

C19H24NO3+ (314.1756)


Lotusine is a member of isoquinolines. Lotusine is a natural product found in Nelumbo nucifera, Magnolia officinalis, and Xylopia parviflora with data available.

   

2-(4-Ethenyl-2,5-dimethylhexa-2,5-dienoxy)-6-(hydroxymethyl)oxane-3,4,5-triol

2-(4-Ethenyl-2,5-dimethylhexa-2,5-dienoxy)-6-(hydroxymethyl)oxane-3,4,5-triol

C16H26O6 (314.1729)


   

(1S)-1-[(4-hydroxyphenyl)methyl]-7-methoxy-2,2-dimethyl-3,4-dihydro-1H-isoquinolin-2-ium-8-ol

(1S)-1-[(4-hydroxyphenyl)methyl]-7-methoxy-2,2-dimethyl-3,4-dihydro-1H-isoquinolin-2-ium-8-ol

C19H24NO3+ (314.1756)


   

(2S,3S)-2-{[(2S)-3-{[(2E)-4-amino-4-oxobut-2-enoyl]amino}-2-azaniumylpropanoyl]amino}-3-methylpentanoate

(2S,3S)-2-{[(2S)-3-{[(2E)-4-amino-4-oxobut-2-enoyl]amino}-2-azaniumylpropanoyl]amino}-3-methylpentanoate

C13H22N4O5 (314.159)


   

(2S,3S)-2-[[(2S)-2-amino-3-[[(E)-4-amino-4-oxobut-2-enoyl]amino]propanoyl]amino]-3-methylpentanoic acid

(2S,3S)-2-[[(2S)-2-amino-3-[[(E)-4-amino-4-oxobut-2-enoyl]amino]propanoyl]amino]-3-methylpentanoic acid

C13H22N4O5 (314.159)


   

[3-Carboxy-2-[4-(carboxymethyl)-3-methylidenepent-4-enoyl]oxypropyl]-trimethylazanium

[3-Carboxy-2-[4-(carboxymethyl)-3-methylidenepent-4-enoyl]oxypropyl]-trimethylazanium

C15H24NO6+ (314.1604)


   

[3-carboxy-2-[(3E,5E)-7-carboxyhepta-3,5-dienoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(3E,5E)-7-carboxyhepta-3,5-dienoyl]oxypropyl]-trimethylazanium

C15H24NO6+ (314.1604)


   

[3-carboxy-2-[(2E,6E)-7-carboxyhepta-2,6-dienoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(2E,6E)-7-carboxyhepta-2,6-dienoyl]oxypropyl]-trimethylazanium

C15H24NO6+ (314.1604)


   

[3-carboxy-2-[(2E,4E)-7-carboxyhepta-2,4-dienoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(2E,4E)-7-carboxyhepta-2,4-dienoyl]oxypropyl]-trimethylazanium

C15H24NO6+ (314.1604)


   

[3-carboxy-2-[(3E,6E)-7-carboxyhepta-3,6-dienoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(3E,6E)-7-carboxyhepta-3,6-dienoyl]oxypropyl]-trimethylazanium

C15H24NO6+ (314.1604)


   

1-[(4-hydroxyphenyl)methyl]-6-methoxy-2,2-dimethyl-3,4-dihydro-1H-isoquinolin-2-ium-7-ol

1-[(4-hydroxyphenyl)methyl]-6-methoxy-2,2-dimethyl-3,4-dihydro-1H-isoquinolin-2-ium-7-ol

C19H24NO3+ (314.1756)


   

3,7-Dibutyl-3,7-dimethyl-2,6-dihydro-[1,2,4]triazolo[1,2-a][1,2,4]triazole-1,5-dithione

3,7-Dibutyl-3,7-dimethyl-2,6-dihydro-[1,2,4]triazolo[1,2-a][1,2,4]triazole-1,5-dithione

C14H26N4S2 (314.1599)


   

3-[(2-ethyl-1-oxobutyl)amino]-N-(2-furanylmethyl)benzamide

3-[(2-ethyl-1-oxobutyl)amino]-N-(2-furanylmethyl)benzamide

C18H22N2O3 (314.163)


   

N-[2-(dimethylamino)ethyl]-2-[3-(4-methylphenyl)-6-oxo-1-pyridazinyl]acetamide

N-[2-(dimethylamino)ethyl]-2-[3-(4-methylphenyl)-6-oxo-1-pyridazinyl]acetamide

C17H22N4O2 (314.1743)


   

N-[2-(3,4-diethoxyphenyl)ethyl]-2-pyridinecarboxamide

N-[2-(3,4-diethoxyphenyl)ethyl]-2-pyridinecarboxamide

C18H22N2O3 (314.163)


   

Ala-Gln-Pro

Ala-Gln-Pro

C13H22N4O5 (314.159)


A tripeptide composed of L-alanine, L-glutamine, and L-proline joined in sequence by peptide linkages.

   

(5R,8R)-8-methyl-5-(phenylmethyl)-3-oxa-1,6,13,14-tetrazabicyclo[9.3.0]tetradeca-11,13-dien-7-one

(5R,8R)-8-methyl-5-(phenylmethyl)-3-oxa-1,6,13,14-tetrazabicyclo[9.3.0]tetradeca-11,13-dien-7-one

C17H22N4O2 (314.1743)


   

1-[(1S,2aR,8bR)-4-acetyl-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-2-yl]-2-cyclopropylethanone

1-[(1S,2aR,8bR)-4-acetyl-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-2-yl]-2-cyclopropylethanone

C18H22N2O3 (314.163)


   

(4R,7R)-4-methyl-7-(phenylmethyl)-9-oxa-1,6,12,13-tetrazabicyclo[9.2.1]tetradeca-11(14),12-dien-5-one

(4R,7R)-4-methyl-7-(phenylmethyl)-9-oxa-1,6,12,13-tetrazabicyclo[9.2.1]tetradeca-11(14),12-dien-5-one

C17H22N4O2 (314.1743)


   

1-[(1R,2aR,8bR)-4-acetyl-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-2-yl]-2-cyclopropylethanone

1-[(1R,2aR,8bR)-4-acetyl-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-2-yl]-2-cyclopropylethanone

C18H22N2O3 (314.163)


   

1-[(1R,2aS,8bS)-4-acetyl-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-2-yl]-2-cyclopropylethanone

1-[(1R,2aS,8bS)-4-acetyl-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-2-yl]-2-cyclopropylethanone

C18H22N2O3 (314.163)


   

1-[(1S,2aS,8bS)-4-acetyl-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-2-yl]-2-cyclopropylethanone

1-[(1S,2aS,8bS)-4-acetyl-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-2-yl]-2-cyclopropylethanone

C18H22N2O3 (314.163)


   
   
   
   
   
   
   

N-[(1-ethylpyrrolidin-2-yl)methyl]-8-fluoro-5H-pyrimido[5,4-b]indol-3-ium-4-amine

N-[(1-ethylpyrrolidin-2-yl)methyl]-8-fluoro-5H-pyrimido[5,4-b]indol-3-ium-4-amine

C17H21FN5+ (314.1781)


   

7-carboxy-N-geranyl-L-gluatamic acid

7-carboxy-N-geranyl-L-gluatamic acid

C15H24NO6+ (314.1604)


   

2-[(3-Butoxy-2-hydroxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[(3-Butoxy-2-hydroxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

C12H29NO6P+ (314.1732)


   

Resiquimod

Resiquimod

C17H22N4O2 (314.1743)


C308 - Immunotherapeutic Agent > C129820 - Antineoplastic Immunomodulating Agent C274 - Antineoplastic Agent

   

dapdiamide C zwitterion

dapdiamide C zwitterion

C13H22N4O5 (314.159)


A peptide zwitterion obtained by transfer of a proton from the carboxy to the amino terminus of dapdiamide C; major species at pH 7.3.

   

dapdiamide B zwitterion

dapdiamide B zwitterion

C13H22N4O5 (314.159)


A peptide zwitterion obtained by transfer of a proton from the carboxy to the amino terminus of dapdiamide B; major species at pH 7.3.

   
   

(2r,3r,4s,5s,6r)-2-{[(1r,5s)-6,6-dimethylbicyclo[3.1.1]hept-2-en-2-yl]methoxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1r,5s)-6,6-dimethylbicyclo[3.1.1]hept-2-en-2-yl]methoxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C16H26O6 (314.1729)


   

1,4-bis(acetyloxy)-3,3,6-trimethylhept-5-en-2-yl acetate

1,4-bis(acetyloxy)-3,3,6-trimethylhept-5-en-2-yl acetate

C16H26O6 (314.1729)


   

(2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-{[(1r,5r)-2-methyl-5-(prop-1-en-2-yl)cyclohex-2-en-1-yl]oxy}oxane-3,4,5-triol

(2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-{[(1r,5r)-2-methyl-5-(prop-1-en-2-yl)cyclohex-2-en-1-yl]oxy}oxane-3,4,5-triol

C16H26O6 (314.1729)


   

(2r,4s)-1,4-bis(acetyloxy)-3,3,6-trimethylhept-5-en-2-yl acetate

(2r,4s)-1,4-bis(acetyloxy)-3,3,6-trimethylhept-5-en-2-yl acetate

C16H26O6 (314.1729)


   

4-(5-oxooxolan-2-yl)butan-2-yl 4,7-dihydroxyoct-2-enoate

4-(5-oxooxolan-2-yl)butan-2-yl 4,7-dihydroxyoct-2-enoate

C16H26O6 (314.1729)


   

4,4a,8a-trihydroxy-5-methoxy-4-methyl-3-(3-methylbut-2-en-1-yl)-tetrahydro-1h-2-benzopyran-6-one

4,4a,8a-trihydroxy-5-methoxy-4-methyl-3-(3-methylbut-2-en-1-yl)-tetrahydro-1h-2-benzopyran-6-one

C16H26O6 (314.1729)


   

(2e)-n-[4-(5-hydroxy-3-methyl-2-oxo-5h-pyrrol-1-yl)butyl]-3-phenylprop-2-enimidic acid

(2e)-n-[4-(5-hydroxy-3-methyl-2-oxo-5h-pyrrol-1-yl)butyl]-3-phenylprop-2-enimidic acid

C18H22N2O3 (314.163)


   

5-{[4-(3-methylbut-2-en-1-yl)-1h-indol-3-yl]methyl}-4,5-dihydro-3h-pyrrole-2,3,4-triol

5-{[4-(3-methylbut-2-en-1-yl)-1h-indol-3-yl]methyl}-4,5-dihydro-3h-pyrrole-2,3,4-triol

C18H22N2O3 (314.163)


   

2-heptyl-3,4,7-trihydroxy-3,7-dimethyl-2h,4h-furo[3,4-b]pyran-5-one

2-heptyl-3,4,7-trihydroxy-3,7-dimethyl-2h,4h-furo[3,4-b]pyran-5-one

C16H26O6 (314.1729)


   

(3r,4r,5s)-5-{[4-(3-methylbut-2-en-1-yl)-1h-indol-3-yl]methyl}-4,5-dihydro-3h-pyrrole-2,3,4-triol

(3r,4r,5s)-5-{[4-(3-methylbut-2-en-1-yl)-1h-indol-3-yl]methyl}-4,5-dihydro-3h-pyrrole-2,3,4-triol

C18H22N2O3 (314.163)


   

2-[(1-hydroxy-4-methylhex-3-en-1-ylidene)amino]-3-(1h-indol-3-yl)propanoic acid

2-[(1-hydroxy-4-methylhex-3-en-1-ylidene)amino]-3-(1h-indol-3-yl)propanoic acid

C18H22N2O3 (314.163)


   

(2r)-4-(5-oxooxolan-2-yl)butan-2-yl (2e,4s,7r)-4,7-dihydroxyoct-2-enoate

(2r)-4-(5-oxooxolan-2-yl)butan-2-yl (2e,4s,7r)-4,7-dihydroxyoct-2-enoate

C16H26O6 (314.1729)


   

(2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-{[(4s)-4-(prop-1-en-2-yl)cyclohex-1-en-1-yl]methoxy}oxane-3,4,5-triol

(2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-{[(4s)-4-(prop-1-en-2-yl)cyclohex-1-en-1-yl]methoxy}oxane-3,4,5-triol

C16H26O6 (314.1729)


   

(2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-({2-[(1r)-4-methylcyclohex-3-en-1-yl]prop-2-en-1-yl}oxy)oxane-3,4,5-triol

(2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-({2-[(1r)-4-methylcyclohex-3-en-1-yl]prop-2-en-1-yl}oxy)oxane-3,4,5-triol

C16H26O6 (314.1729)


   

(5r,8r,16r)-5,13-dihydroxy-8,16-dimethyl-1,9-dioxacyclohexadec-3-ene-2,10-dione

(5r,8r,16r)-5,13-dihydroxy-8,16-dimethyl-1,9-dioxacyclohexadec-3-ene-2,10-dione

C16H26O6 (314.1729)


   

2-(hydroxymethyl)-6-{[2-(4-methylcyclohex-3-en-1-yl)prop-2-en-1-yl]oxy}oxane-3,4,5-triol

2-(hydroxymethyl)-6-{[2-(4-methylcyclohex-3-en-1-yl)prop-2-en-1-yl]oxy}oxane-3,4,5-triol

C16H26O6 (314.1729)


   

(1r)-8-hydroxy-1-[(4-hydroxyphenyl)methyl]-7-methoxy-2,2-dimethyl-3,4-dihydro-1h-isoquinolin-2-ium

(1r)-8-hydroxy-1-[(4-hydroxyphenyl)methyl]-7-methoxy-2,2-dimethyl-3,4-dihydro-1h-isoquinolin-2-ium

[C19H24NO3]+ (314.1756)


   

(2s)-2-{[(2s)-2-amino-1-hydroxy-3-{[(2e)-1-hydroxy-3-(c-hydroxycarbonimidoyl)prop-2-en-1-ylidene]amino}propylidene]amino}-3-methylpentanoic acid

(2s)-2-{[(2s)-2-amino-1-hydroxy-3-{[(2e)-1-hydroxy-3-(c-hydroxycarbonimidoyl)prop-2-en-1-ylidene]amino}propylidene]amino}-3-methylpentanoic acid

C13H22N4O5 (314.159)


   

methyl 3-[(6r)-6-ethyl-11-oxo-7h,8h,9h-pyrido[2,1-b]quinazolin-6-yl]propanoate

methyl 3-[(6r)-6-ethyl-11-oxo-7h,8h,9h-pyrido[2,1-b]quinazolin-6-yl]propanoate

C18H22N2O3 (314.163)


   

7-hydroxy-1-[(4-hydroxyphenyl)methyl]-6-methoxy-2,2-dimethyl-3,4-dihydro-1h-isoquinolin-2-ium

7-hydroxy-1-[(4-hydroxyphenyl)methyl]-6-methoxy-2,2-dimethyl-3,4-dihydro-1h-isoquinolin-2-ium

[C19H24NO3]+ (314.1756)


   

(2e)-n-{4-[(5r)-5-hydroxy-3-methyl-2-oxo-5h-pyrrol-1-yl]butyl}-3-phenylprop-2-enimidic acid

(2e)-n-{4-[(5r)-5-hydroxy-3-methyl-2-oxo-5h-pyrrol-1-yl]butyl}-3-phenylprop-2-enimidic acid

C18H22N2O3 (314.163)


   

(3r,4s,4ar,5s,8as)-4,4a,8a-trihydroxy-5-methoxy-4-methyl-3-(3-methylbut-2-en-1-yl)-tetrahydro-1h-2-benzopyran-6-one

(3r,4s,4ar,5s,8as)-4,4a,8a-trihydroxy-5-methoxy-4-methyl-3-(3-methylbut-2-en-1-yl)-tetrahydro-1h-2-benzopyran-6-one

C16H26O6 (314.1729)


   

(2r,3s,4r,7r)-2-heptyl-3,4,7-trihydroxy-3,7-dimethyl-2h,4h-furo[3,4-b]pyran-5-one

(2r,3s,4r,7r)-2-heptyl-3,4,7-trihydroxy-3,7-dimethyl-2h,4h-furo[3,4-b]pyran-5-one

C16H26O6 (314.1729)


   

(1s)-8-hydroxy-1-[(4-hydroxyphenyl)methyl]-7-methoxy-2,2-dimethyl-3,4-dihydro-1h-isoquinolin-2-ium

(1s)-8-hydroxy-1-[(4-hydroxyphenyl)methyl]-7-methoxy-2,2-dimethyl-3,4-dihydro-1h-isoquinolin-2-ium

[C19H24NO3]+ (314.1756)


   

2-[(1-hydroxyethylidene)amino]-3-[1-(2-methylbut-3-en-2-yl)indol-3-yl]propanoic acid

2-[(1-hydroxyethylidene)amino]-3-[1-(2-methylbut-3-en-2-yl)indol-3-yl]propanoic acid

C18H22N2O3 (314.163)


   

2-(hydroxymethyl)-6-{[2-methyl-5-(prop-1-en-2-yl)cyclohex-2-en-1-yl]oxy}oxane-3,4,5-triol

2-(hydroxymethyl)-6-{[2-methyl-5-(prop-1-en-2-yl)cyclohex-2-en-1-yl]oxy}oxane-3,4,5-triol

C16H26O6 (314.1729)


   

n-[4-(5-hydroxy-3-methyl-2-oxo-5h-pyrrol-1-yl)butyl]-3-phenylprop-2-enimidic acid

n-[4-(5-hydroxy-3-methyl-2-oxo-5h-pyrrol-1-yl)butyl]-3-phenylprop-2-enimidic acid

C18H22N2O3 (314.163)


   

(2s)-2-{[(3e)-1-hydroxy-4-methylhex-3-en-1-ylidene]amino}-3-(1h-indol-3-yl)propanoic acid

(2s)-2-{[(3e)-1-hydroxy-4-methylhex-3-en-1-ylidene]amino}-3-(1h-indol-3-yl)propanoic acid

C18H22N2O3 (314.163)


   

(2e)-n-{4-[(5s)-5-hydroxy-3-methyl-2-oxo-5h-pyrrol-1-yl]butyl}-3-phenylprop-2-enimidic acid

(2e)-n-{4-[(5s)-5-hydroxy-3-methyl-2-oxo-5h-pyrrol-1-yl]butyl}-3-phenylprop-2-enimidic acid

C18H22N2O3 (314.163)


   

2-({6,6-dimethylbicyclo[3.1.1]hept-2-en-2-yl}methoxy)-6-(hydroxymethyl)oxane-3,4,5-triol

2-({6,6-dimethylbicyclo[3.1.1]hept-2-en-2-yl}methoxy)-6-(hydroxymethyl)oxane-3,4,5-triol

C16H26O6 (314.1729)